Top View
- The Black Book of Psychotropic Dosing and Monitoring 2018
- Antipsychotics for Treatment of Delirium in Hospitalised Non-ICU Patients
- Novel Atypical Antipsychotic Agents
- PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
- (12) Patent Application Publication (10) Pub. No.: US 2014/0018348 A1 Javitt (43) Pub
- Multi-Target Approach for Drug Discovery Against Schizophrenia
- New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A
- (12) Patent Application Publication (10) Pub. No.: US 2010/0184806 A1 Barlow Et Al
- Dementia and Antipsychotic Treatment: Literature Search Strategies
- (12) United States Patent (10) Patent No.: US 9.486.453 B2 Javitt (45) Date of Patent: Nov
- The Pipeline and Future of Drug Development In
- National Institute for Health and Care Excellence Surveillance Programme
- Our Company Offers a Number of Other NOTEWORTHY Compounds for Which Custom Quotes Are Available Upon Request
- PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2011) (Rev
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- (12) Patent Application Publication (10) Pub. No.: US 2006/0204486A1 Pyke Et Al
- History of Additional Plasma Metabolic Profile Data Submitted by the Firm HISTORY
- Customs Tariff - Schedule
- Actions of Novel Antipsychotic Agents on Apomorphine-Induced
- Download Product Insert (PDF)
- Treatment of Antipsychotic-Induced Hyperprolactinemia: an Update on the Role of the Dopaminergic Receptors D2 Partial Agonist Aripiprazole
- Novel Antipsychotic Drugs Approved in 2015: Brexpiprazole, Cariprazine
- Meltzer Review
- Customs Tariff - Schedule Xxi - 1
- Synthesis of New 1-Aryl-4-(Biarylmethylene)Piperazine Ligands, Structurally Related to Adoprazine (SLV313)
- Human Neurogenesis Assay: Ramelteon
- The Pipeline and Future of Drug Development in Schizophrenia
- (12) Patent Application Publication (10) Pub. No.: US 2011/0105519 A1 Mendla Et Al
- Involvement of 5-HT1A and 5-HT2A Receptors but Not Α2-Adrenoceptors in the Acute Electrophysiological Effects of Cariprazine in the Rat Brain in Vivo
- Neurogenesis Via Modulation of the Muscarinic Receptors
- Convergent Functional Genomic Studies of Omega-3 Fatty Acids in Stress Reactivity, Bipolar Disorder and Alcoholism
- Different Effects of Bifeprunox, Aripiprazole, and Haloperidol on Body Weight Gain, Food and Water Intake, and Locomotor Activity in Rats
- Recommendations for the Treatment of Schizophrenia with Negative Symptoms
- Design, Synthesis, and Pharmacological Evaluation Of
- Maudsley Prescribing Guidelines, Professor Taylor Is the Author of Several Other Texts and Over 10 10Th Edition a Hundred and Fifty Journal Articles
- Solvay Pharmaceuticals Performance, Priorities and Pipeline Werner Cautreels, General Manager of Solvay Pharmaceuticals
- Sleep Apnea and CMV Driver Safety
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Antipsychotics for Treatment of Delirium in Hospitalised Non-ICU Patients
- Involvement of 5-HT1A and 5-HT2A Receptors but Not Α2
- L:\0900\0900PHARMAPPX .Wpd
- Dopamine Receptor